We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
PTC Therapeutics
PTCT
$5.91B
| $1.08M | 0.01% |
20,817
+13,186
| +173% | +$580K |
|
552
Matrix Service
MTRX
$330M
| $1.08M | 0.01% |
48,264
+20,127
| +72% | +$453K |
|
|
PRE
553
DELISTED
PARTNERRE LTD
PRE
| $1.08M | 0.01% |
9,424
-72,954
| -89% | -$8.32M |
|
|
PEGI
554
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $1.07M | 0.01% |
+43,451
| New | +$1.17M |
|
|
DL
555
DELISTED
China Distance Education Holdings Limited
DL
| $1.06M | 0.01% |
+64,769
| New | +$1.01M |
|
556
TE Connectivity
TEL
$62.3B
| $1.06M | 0.01% |
16,779
-249,415
| -94% | -$15M |
|
557
Corpay
CPAY
$26B
| $1.06M | 0.01% |
7,134
+251
| +4% | +$36.2K |
|
558
Pentair
PNR
$11.2B
| $1.03M | 0.01% |
+23,182
| New | +$1.02M |
|
|
PRA
559
DELISTED
ProAssurance
PRA
| $1.03M | 0.01% |
+22,897
| New | +$1.05M |
|
|
WNR
560
DELISTED
Western Refining Inc
WNR
| $1.03M | 0.01% |
27,368
+21,243
| +347% | +$879K |
|
|
NVRO
561
DELISTED
NEVRO CORP.
NVRO
| $1.02M | 0.01% |
+26,502
| New | +$834K |
|
562
Hancock Whitney
HWC
$6.22B
| $1.02M | 0.01% |
33,084
+23,214
| +235% | +$754K |
|
563
Lowe's Companies
LOW
$122B
| $1.01M | 0.01% |
14,649
-5,498
| -27% | -$329K |
|
|
ACHN
564
DELISTED
Achillion Pharmaceuticals
ACHN
| $1M | 0.01% |
+81,984
| New | +$1M |
|
565
Guidewire Software
GWRE
$13.3B
| $1M | 0.01% |
+19,816
| New | +$975K |
|
|
SF
566
Stifel
SF
$12.6B
| $1M | 0.01% |
+44,116
| New | +$934K |
|
|
GRA
567
DELISTED
W.R. Grace & Co.
GRA
| $991K | 0.01% |
10,390
-2,317
| -18% | -$216K |
|
568
ONE Gas
OGS
$5B
| $979K | 0.01% |
+23,743
| New | +$922K |
|
569
Archer Daniels Midland
ADM
$37.4B
| $971K | 0.01% |
+18,670
| New | +$931K |
|
570
Rockwell Medical
RMTI
$28.3M
| $960K | 0.01% |
849
+548
| +182% | +$562K |
|
571
Sysco
SYY
$40.4B
| $960K | 0.01% |
+24,201
| New | +$938K |
|
|
CTCM
572
DELISTED
CTC MEDIA INC COM STK
CTCM
| $957K | 0.01% |
+196,540
| New | +$1.09M |
|
|
SINA
573
DELISTED
Sina Corp
SINA
| $948K | 0.01% |
25,337
+8,573
| +51% | +$333K |
|
|
TXNM
574
TXNM Energy Inc
TXNM
$5.92B
| $941K | 0.01% |
+31,764
| New | +$900K |
|
575
Urban Outfitters
URBN
$6.65B
| $936K | 0.01% |
26,626
-7,254
| -21% | -$235K |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.